229 related articles for article (PubMed ID: 10069875)
41. [Corticosteroid therapy of asthma].
Chanez P; Vachier I; Michel FB; Bousquet J; Godard P
Presse Med; 2000 Sep; 29(16):1469-78. PubMed ID: 11039095
[TBL] [Abstract][Full Text] [Related]
42. Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma.
Jakobsson T; Croner S; Kjellman NI; Pettersson A; Vassella C; Björkstén B
Allergy; 1994 Jul; 49(6):413-20. PubMed ID: 8074263
[TBL] [Abstract][Full Text] [Related]
43. Epidemiological and clinical characteristics, spirometric parameters and response to budesonide/formoterol in patients attending an asthma clinic: an experience in a developing country.
Imad H; Yasir G
Pan Afr Med J; 2015; 21():154. PubMed ID: 26327991
[TBL] [Abstract][Full Text] [Related]
44. Update on glucocorticoid action and resistance.
Ito K; Chung KF; Adcock IM
J Allergy Clin Immunol; 2006 Mar; 117(3):522-43. PubMed ID: 16522450
[TBL] [Abstract][Full Text] [Related]
45. Individual variations in lymphocyte-responses to glucocorticoids in patients with bronchial asthma: comparison of potencies for five glucocorticoids.
Hirano T; Homma M; Oka K; Tsushima H; Niitsuma T; Hayashi T
Immunopharmacology; 1998 Jul; 40(1):57-66. PubMed ID: 9776479
[TBL] [Abstract][Full Text] [Related]
46. Expression of nonmuscle cofilin-1 and steroid responsiveness in severe asthma.
Vasavda N; Eichholtz T; Takahashi A; Affleck K; Matthews JG; Barnes PJ; Adcock IM
J Allergy Clin Immunol; 2006 Nov; 118(5):1090-6. PubMed ID: 17088134
[TBL] [Abstract][Full Text] [Related]
47. Asthma stability after oral prednisone: a clinical model for comparing inhaled steroid potency.
Ahrens RC; Teresi ME; Han SH; Donnell D; Vanden Burgt JA; Lux CR
Am J Respir Crit Care Med; 2001 Oct; 164(7):1138-45. PubMed ID: 11673199
[TBL] [Abstract][Full Text] [Related]
48. IVIG therapy in pemphigus vulgaris has corticosteroid-sparing and immunomodulatory effects.
Svecova D
Australas J Dermatol; 2016 May; 57(2):141-4. PubMed ID: 26581165
[TBL] [Abstract][Full Text] [Related]
49. Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial.
Hashimoto S; Brinke AT; Roldaan AC; van Veen IH; Möller GM; Sont JK; Weersink EJ; van der Zee JS; Braunstahl GJ; Zwinderman AH; Sterk PJ; Bel EH
Thorax; 2011 Jun; 66(6):514-20. PubMed ID: 21474498
[TBL] [Abstract][Full Text] [Related]
50. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
[TBL] [Abstract][Full Text] [Related]
51. Steroid response in refractory asthmatics.
Jang AS
Korean J Intern Med; 2012 Jun; 27(2):143-8. PubMed ID: 22707883
[TBL] [Abstract][Full Text] [Related]
52. New insights into steroid resistant asthma.
Leung DY; Szefler SJ
Pediatr Allergy Immunol; 1998 Feb; 9(1):3-12. PubMed ID: 9560836
[TBL] [Abstract][Full Text] [Related]
53. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta.
Leung DY; Hamid Q; Vottero A; Szefler SJ; Surs W; Minshall E; Chrousos GP; Klemm DJ
J Exp Med; 1997 Nov; 186(9):1567-74. PubMed ID: 9348314
[TBL] [Abstract][Full Text] [Related]
54. Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study.
Pelaia C; Calabrese C; Barbuto S; Busceti MT; Preianò M; Gallelli L; Savino R; Vatrella A; Pelaia G
Pulm Pharmacol Ther; 2019 Feb; 54():25-30. PubMed ID: 30414440
[TBL] [Abstract][Full Text] [Related]
55. Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma.
Qureshi F; Zaritsky A; Poirier MP
J Pediatr; 2001 Jul; 139(1):20-6. PubMed ID: 11445789
[TBL] [Abstract][Full Text] [Related]
56. Repeated Allergen Exposure in A/J Mice Causes Steroid-Insensitive Asthma via a Defect in Glucocorticoid Receptor Bioavailability.
Serra MF; Cotias AC; Pão CRR; Daleprane JB; Jurgilas PB; Couto GC; Anjos-Valotta EA; Cordeiro RSB; Carvalho VF; Silva PMR; Martins MA
J Immunol; 2018 Aug; 201(3):851-860. PubMed ID: 29914889
[TBL] [Abstract][Full Text] [Related]
57. Diagnosis and management of steroid-resistant asthma.
Leung DY; Szefler SJ
Clin Chest Med; 1997 Sep; 18(3):611-25. PubMed ID: 9329880
[TBL] [Abstract][Full Text] [Related]
58. Glucocorticoid receptor-binding characteristics in severe asthma.
Bonnans C; Chanez P; Meziane H; Godard P; Bousquet J; Vachier I
Eur Respir J; 2003 Jun; 21(6):985-8. PubMed ID: 12797492
[TBL] [Abstract][Full Text] [Related]
59. Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris.
Sami N; Qureshi A; Ruocco E; Ahmed AR
Arch Dermatol; 2002 Sep; 138(9):1158-62. PubMed ID: 12224976
[TBL] [Abstract][Full Text] [Related]
60. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use.
Searing DA; Zhang Y; Murphy JR; Hauk PJ; Goleva E; Leung DY
J Allergy Clin Immunol; 2010 May; 125(5):995-1000. PubMed ID: 20381849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
